1216 CHAPTER 30 The Organic Chemistry of Drugs
has the same imidazole ring as 4-methylhistidine, but it has a sulfur atom
and a functional group based on guanidine (Section 23.1). has a different het-
erocyclic ring, and although its side chain is similar to that of it does not
contain a guanidino group.
Observations that serotonin was implicated in the generation of migraine attacks
led to the development of drugs that bind to serotonin receptors. Sumatriptan, intro-
duced in 1991, relieved not only the pain associated with migraines, but also many of
migraine’s other symptoms, including sensitivity to light and sound and nausea.
The success of sumatriptan spurred a search for other antimigraine agents by molecular
modification, and three new triptans were introduced in 1997 and 1998. These
second-generation triptans showed some improvements over sumatriptan—specifically,
a longer half-life, reduced cardiac side effects, and improved CNS penetration.
In screening modified compounds, it is not unusual to find a compound with a com-
pletely different pharmacological activity than the lead compound. For example, a
molecular modification of a sulfonamide, an antibiotic, led to tolbutamide, a drug with
hypoglycemic activity (Section 25.8).
a sulfonamide
H 2 NNHRS
O
O
S
O
O
H 3 C NH C NHCH 2 CH 2 CH 2 CH 3
O
tolbutamide
HO
H
N
CH 2 CH 2 NH 2
serotonin
H
N
CH 2 CH 2 NCH 3
CH 3
sumatriptan
Imitrex
CH 3 NH S
O
O
Tagamet®,
Zantac®
Tagamet®
Tutorial:
Structural similarities in classes
of drugs
NHCH 3 CH 2 SCH 2 CH 2 NH NHCH 3
N
N
H
CH 2 CH 2 NH 3
NO 2
CH 3
+
+
+
CN
C
C
HH
N
C
CH 3 NHCH 2 O
CH 3
4-methylhistamine
cimetidine
Tagamet
ranitidine
Zantac
N
N
H
CH 2 SCH 2 CH 2 NH
CH 3
O
O
H
H N
N
CH 2 CH 2 NCH 3
CH 3
zolmitriptan
Zomig
H
N
NCH 3
naratriptan
Amerge
H
N
N
N
CH 2 CH 2 NCH 3
CH 3
rizatriptan
Maxalt
N
CH 3 NH S
O
O
BRUI30-1204_ 1228r2 18-03-2003 8:55 AM Page 1216